开封市社会医疗保险参保人员流感疫苗成本效益分析  

Cost-benefit analysis on the strategy of social health insurance regarding vaccination against influenza in Kaifeng

作　　者：孙龙[1] 陆寒[1] 李柯[1] 黄昌红[1] 丁帅[1] 

机构地区：[1]开封市疾病预防控制中心免疫预防与规划科,河南开封475004

出　　处：《现代预防医学》2013年第13期2458-2459,共2页Modern Preventive Medicine

摘　　要：目的评价社会医疗保险参保人员接种流感疫苗的成本效益。方法对符合研究对象的7000名参保职工,用随机抽样方法,抽取2626人,进行问卷调查。采用历史性队列研究方法,对接种组和对照组进行回顾性调查。结果流感疫苗接种后与接种前相比年人均感冒发病降低1.92次,降低64.43%(P﹤0.05);接种流感疫苗比未种人群流感年人均发病次数降低0.95次,降低47.26%(P﹤0.05);接种疫苗后,出现发热等一般反应占7.17%,轻度过敏反应占1.81%。结论接种流感疫苗是目前预防流感安全有效的措施,对全市参保的人员具有较高的成本效益。OBJECTIVE To evaluate the effect of influenza vaccination among citizen of social health insurance in Kaifeng. METHODS A retrospective cohort study was conducted.2 626 citizens were sampled with random sampling method from 7 000 citizens with social health insurance who were consistent with the study requirements. Investigation with questionnaires was carried out among 2 626 citizens. RESULTS Per capita annual incidence of after influenza vaccination was decreased 1.92 than before influenza vaccination, ratio was decreased 64.43% （P 〈 0.05）. Per capita annual incidence of vaccine group was decreased 0.95 than control group, ratio was decreased 47.26% （P 〈 0.05）. Among inoculation reaction, ratio of general re- actions was 7.17%. The ratio of mild allergic reactions was 1.81%. CONCLUSION Influenza vaccination is the safe and ef- fective measure to prevent influenza, which has gained better economic benefit.

关 键 词：流感疫苗 成本效益 社会医疗保险 

分 类 号：R186[医药卫生—流行病学]